trial · primary record
Azacitidine
Leukemia, Myeloid, Acute
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 103 |
| Primary completion | 2027-05-15 |
| Primary endpoint | Percentage of Participants With Complete Remission (CR) |
| Registry ID | NCT04023526 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:45.597Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04023526
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Azacitidine · approval
- Azacitidine · compound